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Abstract 
Abnormal regulation of Sonic hedgehog (Shh) signaling has been described in a variety of human 
cancers and developmental anomalies, which highlights the essential role of this signaling molecule 
in cell cycle regulation and embryonic development. Gas1 and Boc are membrane co-receptors for 
Shh, which demonstrate overlapping domains of expression in the early face. This study aims to 
investigate potential interactions between these co-receptors during formation of the secondary 
palate. Mice with targeted mutation in Gas1 and Boc were used to generate Gas1; Boc compound 
mutants. The expression of key Hedgehog signaling family members was examined in detail during 
palatogenesis via radioactive in situ hybridization. Morphometric analysis involved computational 
quantification of BrdU-labeling and cell packing; whilst TUNEL staining was used to assay cell 
death. Ablation of Boc in a Gas1 mutant background leads to reduced Shh activity in the palatal 
shelves and an increase in the penetrance and severity of cleft palate, associated with failed 
elevation, increased proliferation and reduced cell death. Our findings suggest a dual requirement 
for Boc and Gas1 during early development of the palate, mediating cell cycle regulation during 
growth and subsequent fusion of the palatal shelves. 
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Introduction 
Development of the mammalian secondary palate is a complex process, which requires a 
coordinated network of molecular and cellular events to produce appropriate growth, elevation and 
fusion of the constituent palatal shelves [1-3]. In humans, palatogenesis occurs relatively early in 
development, taking place between 5 and 12 weeks of intrauterine life [4]. In the mouse, this 
process is remarkably similar to that in the human, but occurs more rapidly between embryonic 
stages (E) 10.5 and E15.5 [5]. Formation of the secondary palate begins with the appearance of two 
outgrowths from the maxillary process (palatal shelves, PS), which grow vertically to flank the 
lateral borders of the developing tongue (Figure 1B) [6, 7]. The PS subsequently elevate to a 
horizontal position above the tongue, which itself descends to help facilitate this process. Following 
elevation, medial growth of the paired PS towards the midline results in contact and then fusion 
with each other. During this stage, a transient medial epithelial seam (MES) is generated from the 
adhered epithelia [8, 9], which progressively disappears as midline confluence is achieved. The 
secondary PS also fuse with the primary palate anteriorly at the incisive foramen and complete 
confluence is usually observed around the twelfth week of human embryogenesis (E15.5 in mice) 
(Figure 1) [4, 8]. 
 The Hedgehog (Hh) family of signaling molecules have emerged as major contributors to 
the developmental process in a wide variety of organisms, coordinating cell proliferation, survival 
and differentiation in multiple tissues [10-13]. Dysfunction of Hh signaling underlies a number of 
human developmental abnormalities and diseases, making it an important therapeutic target [10]. 
More specifically, genetic defects in the pathway can cause Holoprosencephaly (HPE) [14] or 
complex genetic diseases, such as Pallister–Hall syndrome [15] and Basal Cell Nevus Syndrome 
(BCNS) [16-18]. The Hh signaling pathway can undergo aberrant activation through the 
overexpression of Hh ligands, loss of receptor and co-receptor function or dysregulation of 
downstream transcription factors. All these aberrations in Hh signaling have been implicated in the 
initiation and progression of multiple cancer types, including breast, prostate, hepatocellular, 
pancreatic and brain cancers [11]. Sonic hedgehog (Shh) is the most comprehensively studied 
member of the Hh family [10] with the secreted ligand binding the primary Patched-1 (Ptch1) 
receptor to effect signal transduction [19, 20]. In the absence of ligand, Ptch1 acts as a ligand-
independent inhibitor of the transmembrane protein Smoothened (Smo), a positive regulator of the 
pathway [10, 21, 22]. This regulation of Shh activity takes place in the primary cilium, by an as yet 
undefined mechanism [23-26]. Once the repression exerted by Ptch1 is released by Shh binding, 
increased ciliary levels of Smo lead to active transcription of Gli (Glioma-associated oncogene 
family members) transcription factors, through binding of specific consensus sequences located in 
the promoter region of target genes [10, 21]. More recently, the complexity of Shh signal regulation 
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has become further evident as new proteins involved in modulating the pathway have been 
uncovered [21]. Among these, Growth arrest-specific 1 (Gas1) [27, 28], Cell-adhesion-molecule-
related/downregulated by oncogenes (Cdon) [29, 30] and Biregional Cdon-binding protein (Boc) 
have been established as essential co-receptors that promote Shh signal transduction within a 
number of developmental contexts [31, 32]. Interestingly, some mutations causing HPE impair the 
palmitate-dependent interaction between Shh and Ptch1 [33, 34]. This interaction is also abolished 
in the BCNS, a congenital predisposition to cancers driven by hyperactive Hh signaling, such as 
basal cell carcinoma and medulloblastoma [34]. Not surprisingly, the features of HPE and 
aggressive basal-cell carcinomas have been previously reported in the same individual [35]. 
 Gas1 is a N-glycosylated glycosylphosphatidyl inositol (GPI)-linked plasma membrane 
protein originally isolated via differential screening of fibroblasts maintained under growth arrest 
[36, 37]. Subsequently, GAS1 was mapped to human chromosome 9q21.3-22.1 and established as a 
negative cell cycle regulator and tumor suppressor [38]. The first link between Hh signaling and 
Gas1 was established through immunoprecipitation assays demonstrating Gas1 as capable of 
binding Shh and reducing its action [39]. However, subsequent in vivo studies have argued against 
these initial in vitro observations [27, 28, 40, 41]. Analysis of Gas1 mutant mice have demonstrated 
malformations characteristic of Shh loss-of-function, including micropthalmia [42], HPE [27, 28], 
axon guidance deficiency and neural tube patterning defects [40, 41]. Moreover, depletion of Shh 
dosage in a Gas1 mutant background leads to even more severe developmental defects [40]. These 
correlations and genetic interactions support the view that Gas1 is a positive component of the Shh 
signaling pathway [27, 28, 40]. Boc was identified via screening of a human fetal brain cDNA 
library using a rat Cdon cDNA probe [43]. Biochemical analysis depicts Boc with a single 
transmembrane domain and four immunoglobulin like loops plus three fibronectin type III (FNIII) 
repeats in its ectodomain [43, 44]. BOC localizes to the plus strand of human chromosome 3q13.2 
[45]. A study on the guidance of commissural axons in mice provided evidence to correlate Boc and 
Shh signaling [46]. Boc was shown to act as a receptor, capable of interacting directly with Shh via 
its third FNIII repeat (FNIIIc) [46]. Moreover, immunopreciptation experiments demonstrated that 
Boc can also physically bind to Ptch1 [31]. Interestingly, the presence of Shh does not alter the 
ability of Ptch1 to bind Boc, suggesting a constitutive interaction [31]. Recently, mutations 
affecting CDON disrupted its ability to interact with GAS1 and PTCH1, reinforcing the importance 
of these interactions for appropriate SHH signal reception. This mutation-induced disruption of 
interactions between SHH co-receptors has been shown to be a mechanism in HPE, a congenital 
anomaly associated with diminished Shh activity [47]. Taken together, these data have established 
the concept that these molecules can act as Hh co-receptors [32]. 
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 Shh transcriptional activity is detected in epithelium of the developing PS [48, 49] and the 
ligand plays a key role in mediating palatal outgrowth and patterning through an interaction with 
Fgf10 in the underlying mesenchyme [50]. Shh is also involved in a further regulatory feedback 
loop between epithelium and mesenchyme during growth of the PS, interacting with Bmp4 and 
Msx1 to induce proliferation in the mesenchyme [51]. Shh is also able to promote cell proliferation 
in the palatal mesenchyme via the activation of additional transcription factors, including Foxf1a, 
Foxf2 and Osr2 [52, 53]. More recently, tissue-specific deletion of Pax9 from mesenchyme of the 
PS has been shown to indirectly regulate Shh expression in the adjacent epithelium and 
downregulate key targets in the mesenchyme (Bmp4, Fgf10 and Msx1), placing Pax9 upstream of 
this complex gene network [54, 55]. Gas1-/- mice also demonstrate cleft of the secondary palate 
(CP) with 50% penetrance, which is associated with reduced Shh signal transduction [28]. We have 
previously demonstrated that fine-tuning of Shh transduction is also crucial for PS fusion. The PS 
of transgenic mice overexpressing Shh in the PS epithelium under control of a Keratin-14 promotor 
(K14-Shh) demonstrate reduced cell death in the MEE, which prevents PS fusion [56]. Collectively, 
these findings highlight the importance of undisturbed Shh signaling during the events underlying 
normal palatogenesis. 
 There are currently over one thousand identified loci associated with orofacial clefting [57], 
but only around half of these have a defined molecular basis [58]. A precise integration between 
cell cycle regulation and cell-type specification is required during embryogenesis to direct the 
appropriate formation and function of each tissue. Gas1 and Boc have been shown to be key for 
harmonious integration of these two programs [31, 59-61]. Furthermore, disruption of Gas1 and 
Boc has highlighted their importance in human diseases, including cancer [59, 62-64]. In the present 
investigation, we aim to further elucidate potential interactions between Gas1 and Boc during cell 
cycle regulation in the developing palate. Significantly, ablation of Boc in a Gas1 mutant 
background led to reduced Shh activity in the PS and increased severity of the CP phenotype. This 
was associated with failed PS elevation, increased mesenchymal proliferation and reduced epithelial 
cell death. Our findings suggest a dual requirement for Boc and Gas1 during early palatogenesis, 
mediating cell proliferation during growth and cell survival during subsequent PS fusion. 
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Results 
Normal expression of Shh, Ptch1, Gas1 and Boc during secondary palate development 
Shh transcriptional activity was observed in the developing rugae of the PS oral epithelium between 
E12.5-14.5 (Figure 2A-C), with transient transcriptional activity also seen in the future MEE region 
at E12.5 (Figure 2A). Shh signaling was therefore active during growth and elevation of the PS and 
confirmed by the presence of strong Ptch1 expression in condensed mesenchyme adjacent to 
regions of Shh expression (Figure 2D-F). However, Ptch1 expression was not observed in the MES 
during fusion (Figure 2F). Gas1 showed widespread expression within PS mesenchyme during 
growth of these structures in regions adjacent to those expressing Ptch1 (Figure 2G-I). Interestingly, 
Gas1 was also upregulated in nasal epithelium of the PS following fusion (Figure 2I). In contrast, 
Boc showed diffuse low-level transcription in PS mesenchyme but strong expression within the 
epithelium at E12.5 (Figure 2J). Although the epithelial expression was somewhat downregulated at 
E13.5 (Figure 2K), transcripts were still observed in the mesenchyme. Following PS elevation and 
fusion, Boc transcriptional activity was detected throughout the oral palatal epithelium and within 
the region of the MES (Figure 2L). 
 
Interactions between Gas1 and Boc during palatogenesis 
Histological analysis of Gas1+/-; Boc+/- mice demonstrated a craniofacial midline comparable to 
wild type mice, with normal palatal development (Figure 3A-C). Gas1-/-; Boc+/- mice exhibited 
microfom HPE, which has been previously described in Gas1-/- mice [28, 61] and includes CP with 
incomplete penetrance (Figure 3D-F). In agreement with previous investigations, Boc-/- mice were 
viable, did not display any gross craniofacial phenotype and could not be distinguished from their 
wild type littermates [30, 31, 61]. Moreover, palatal development was not affected by an absence of 
Boc function (Figure 3G-I). In contrast, Gas1-/-; Boc-/- compound mutant mice exhibited a fully 
penetrant CP associated with a failure of PS elevation above the tongue (Figure 3J-L). In addition, 
an abnormally positioned vomeronasal organ was observed and a cleft tongue present in the 
pharyngeal region (Figure 3L). Significantly, the more severe craniofacial phenotype observed in 
Gas1; Boc compound mutants was associated with a reduction in expression levels of the Shh target 
genes Ptch1 and Gli1, respectively (Figure 4A-C; D-F). However, transcriptional activity of Shh 
was seemingly unaltered when compared to control Gas1+/-; Boc+/- mice (Figure 4G-I). 
 
Palatal shelf mesenchymal cell packing and proliferation indices in the absence of Gas1 and 
Boc function 
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The phenotypic analysis of Gas1 and Boc single and compound mutant mice was suggestive of a 
role for these co-receptors during the regulation of PS growth. We therefore analysed the PS 
phenotype in these mutants at the cellular level, specifically focusing on the mesenchymal 
component. In mesenchymal tissues, the extracellular matrix can contribute significantly to tissue 
volume, therefore we also incorporated a measure of cell spacing [65]. Specifically, we generated a 
cell packing index (CPI) and a proliferation index per unit area (PIPUA) within the PS using image 
segmentation to determine total and BrdU-positive cells within the mesenchyme [66]. A descriptive 
analysis of the CPI is shown in Tables 
 
Table 1, containing the number of PS analysed for each genotype, the median, range and 
interquartile range. Kruskal-Wallis test revealed a statistical significant difference among the four 
genotypes analyzed (p<0.001). Table 2 illustrates the Poisson regression analysis performed to 
evaluate CPI differences among the genotypes. Post hoc pairwise comparisons demonstrated that 
the only non-statistical significant result was the CPI difference between Gas1-/-; Boc-/- and Gas1+/-; 
Boc+/- PS (p = 0.636) (  
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Figure 6B). In fact, the same median was observed for both groups (Gas1-/-; Boc-/- and Gas1+/-; 
Boc+/-) (Tables 
 
Table 1). Gas1-/-; Boc+/- PS showed a higher CPI compared to control (Gas1+/-; Boc+/-); whereas 
Boc-/- PS showed the lowest CPI amongst genotypes (  
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Figure 6B, Table 2). The CPI is a measure of cell density; that is the number of cells per region of 
interest. It then follows that upon comparison of two samples (e.g. Gas1+/-; Boc+/- versus Gas1-/-; 
Boc-/-) if the cell density is constant, any differences in the PIPUA denotes a true change in 
proliferation as a result of mutation in Gas1 and Boc or genetic interaction. Analysis of the PIPUA 
revealed a statistical significant difference among the four genotypes (p <0.001). Table 3 illustrates 
descriptive analysis for the PIPUA, containing the number of PS analysed for each genotype, the 
median, range and interquartile range. Post hoc pairwise comparisons among groups revealed a 
statistical significant difference between PIPUA amongst all genotypes, except for Gas1-/-; Boc-/- 
versus Gas1-/-; Boc+/- (  
10 
 
 
Figure 6D). Table 4 illustrates the Poisson regression analysis performed to evaluate PIPUA 
differences among the genotypes. The PIPUA of Boc-/- PS showed the highest value (2612.54, 
p<0.001), whilst Gas1-/-; Boc+/- and Gas1-/-; Boc-/- PS also demonstrated a higher PIPUA compared 
to control, but to a lesser extent (Table 4,   
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Figure 6D). 
 
Palatal shelf cell survival in the absence of Gas1 and Boc function 
Regression of the MES is an important step during palatogenesis and contributes to formation of a 
confluent secondary palate [5]. Programmed cell death (apoptosis) is one of the proposed 
mechanisms involved in mediating MES degeneration [58, 67]. In the present study, we assayed the 
presence of apoptotic cells using TUNEL assays. Interestingly, we found similar levels of apoptosis 
in the anterior, medial and posterior sections of Boc-/- PS when compared to corresponding sections 
of Gas+/-; Boc+/- PS (Figure 7G'-I'; A'-C', respectively). Conversely, the levels of cell death within 
Gas-/-; Boc+/- (Figure 7D'-F') and Gas-/-; Boc-/- PS was reduced in relation to Gas+/-; Boc+/-. 
 
Discussion 
Understanding the role of Shh during palatogenesis is important because of the key regulatory role 
this signaling protein plays during development of this structure [68]. Gas1 and Boc are now 
established as essential Shh co-receptors during development and are required for regulating Shh-
mediated cell proliferation in other regions of the embryo [31, 32]. Shh pathway components 
demonstrate distinct regional expression in the PS during development [28, 49, 50] and here we 
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have shown non-overlapping domains between Ptch1, Gas1 and Boc in the epithelium and 
mesenchyme during palatogenesis. Recent evidence suggests that the co-receptor function exerted 
by Gas1 and Boc in combination with Ptch1 is unlikely to involve all three molecules in the same 
complex [31]. The observed Boc expression pattern shows evidence for redundancy with Gas1 in 
the palate, as previously demonstrated in other regions of the developing embryo, such as the neural 
tube and heart [32]. 
 Ablation of Boc activity in a Gas1 mutant background leads to a unique form of HPE [61]. 
Although Boc-/- mice were viable and fertile with no overt embryonic phenotype (Figure 3G-I), 
Gas1-/-; Boc-/- embryos show defects not previously observed in mice lacking Gas1 activity [28, 
61]. Of relevance to palatal development, Gas1; Boc compound mutants exhibited a fully penetrant 
CP, associated with failed elevation of the PS. Other phenotypes included clefting of the posterior 
tongue and abnormal positioning of the vomeronasal organ. These characteristics correlate with a 
reduction of Shh signaling, which seems more drastically affected in Gas1; Boc compound mutants 
(Figure 4). Similarly, in the context of limb development, a more severe defect in digit patterning 
and specification is observed in Gas1; Boc compound mutants [32]. In addition, Gas1 and Boc in 
conjunction with Cdon have recently been shown to modulate the levels of Hh-responsiveness in 
the pathogenesis of pancreatic cancer. When all three co-receptors are ablated intra-tumoral 
proliferation is reduced, highlighting the importance of combined mutagenesis screens when 
describing pathway function [62]. 
 Whole population cell analysis of the PS epithelium has highlighted the importance of 
considering factors other than cell proliferation in isolation when evaluating tissue growth [65]. 
Here we focused on the mesenchyme, as elevation and growth of the PS is likely to be driven by 
changes in the mesenchymal stroma [8]. In order to determine the effects of targeted mutations in 
Gas1 and Boc on the developing PS, BrdU and TUNEL assays were performed. A CPI and a 
PIPUA were implemented in order to generate an unbiased proliferation map of the entire PS 
mesenchyme (rather than randomly selecting isolated areas of tissue) taking into account the 
interdependent relationship of the two quantities [28, 56, 65, 69]. However, Boc-/- PS presented a 
decreased cell density (CPI) and increased proliferation (PIPUA) in comparison to control (Gas+/-; 
Boc+/- mice). These seemingly conflicting results can be explained by two possible mechanisms: (1) 
either an increased compensatory apoptosis, resulting in a net reduction in cell number or (2) an 
increase in the average distance between cells as a result of an increase in overall tissue size. The 
former hypothesis can be excluded following the apoptosis analysis, which demonstrated cell death 
present primarily in the epithelium at levels similar to those observed in Gas+/-; Boc+/- PS (Figure 
7). Similar results in terms of cell death have also been observed in a different context (cerebellar 
granule neuron progenitors), where Boc ablation does not affect apoptosis [31]. As no overt 
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differences were observed in overall tissue size, the alternative hypothesis would require further 
analysis (whereby cell distances are measured directly) in order to determine the precise causation 
of a cell proliferation increase with concomitant cell packing decrease. In Gas-/-; Boc+/- PS there 
was increased PIPUA accompanied by an increased CPI. This suggests a more straightforward 
relationship between Gas1 and proliferation, whereby Gas1 acts as a negative regulator of cell 
proliferation in the PS mesenchyme. This is in agreement with other studies demonstrating that 
Gas1 is capable of initiating apoptosis and inhibiting proliferation [70, 71]. Interestingly, Gas1 
exerts similar functions in oncogenesis [63, 72]. Gas1 activity detains tumour growth by inhibiting 
the proliferation of breast cancer cells [63] and has been reported to play the same mechanistic role 
in a variety of other cancers; such as colorectal carcinoma [72], papillary thyroid carcinoma [64] 
and glioma [70]. In Gas-/-; Boc-/- PS the CPI was restored to levels observed in Gas+/-; Boc+/- 
suggesting that the two genes have opposing roles in regulating cell density. However, their 
relationship with respect to proliferation regulation appears to be more complex and non-
synergistic, as demonstrated by the (significantly higher) PIPUA observed in the Gas-/-; Boc-/- PS. 
Although both genes seem to be negative regulators of proliferation in this developmental context, 
it is highly suggestive that additional regulators play a role in this network. Moreover, higher CPI 
and PIPUA are not necessarily an indication of aberrant palatogenesis, as observed in Boc-/- 
embryos. Therefore, it is reasonable to speculate that the HPE midline facial anomalies present in 
Gas1-/-; Boc-/- [61] could play an important role in the CP phenotype observed in these mice. 
 We have excluded tissue packing changes as a potential cellular mechanism underlying the 
Gas1; Boc mutant PS phenotype. Histological analysis demonstrated that the Gas1-/-; Boc-/- PS size 
are similar to that of Gas+/-; Boc+/-. Therefore, in order to further understand how the observed 
differences in proliferation contribute to the CP phenotype, a direct measure of the overall midfacial 
region of Gas1-/-; Boc-/- mice would be required. This may prove challenging to perform in plane 
section, because no account would be taken of cellular movements and rearrangements that might 
be taking place in the z- dimension [65, 69]. Alternative approaches might include three-
dimensional and potentially live imaging, and cell tracking to encompass cellular rearrangements; 
these techniques would underpin our future studies. Recent reports of extensive cellular 
rearrangements in oral epithelia render this scenario plausible [73]. Similar experimental 
approaches could be adopted to further elucidate the links between genetic lesions and the cellular 
mechanistic defects underlying the CP phenotype. We have previously demonstrated that increased 
transduction of Shh signaling in the PS mesenchyme leads to reduced proliferation [56]. The results 
of the present study illustrate an opposite effect (increased PIPUA in Gas1-/-; Boc-/- mice) that 
correlates with reduced transcriptional activity of Shh signaling readouts. Furthermore, deletion of 
Gas1 leads to reduced apoptosis in the PS. Although the CP phenotype in mice lacking Gas1 [28] 
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or in compound Gas1; Boc mutants is associated with PS that fail to elevate above the tongue; it is 
unlikely that the PS would fuse, as demonstrated by transgenic mice over-expressing Shh in the oral 
epithelium [56]. 
 The results from this study further highlight the importance of Shh signaling in coordinating 
the process of palatogenesis. Hh family members are expressed at key stages during palate 
development [49, 56, 61]. Moreover, ablation of Boc in a Gas1 mutant background leads to reduced 
transduction of Shh signaling. Morphometric analysis revealed that the more severe clefting 
phenotype observed in these mice was associated with higher proliferation levels and reduced 
apoptosis. Additional mRNA expression analysis of known mediators of palatal development may 
help to further define a gene network in developing palate. While systems approaches are important 
to elucidate the vast molecular network regulating complex developmental processes such as 
palatogenesis, understanding the role of individual genes implicated in cell regulation is also highly 
valuable. This study has directly addressed the role of two key Hh signaling components and their 
dual requirement for orchestrating palatogenesis. Similar studies addressing the roles of other key 
Hh components should eventually lead to a more complete picture of the genetic basis of midline 
development and how it relates to human syndromic disorders. 
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Materials and Methods 
Generation of Gas1; Boc compound mutant mice 
All mice were housed and all experiments conducted in compliance with the approved protocols at 
King’s College London, UK and the Carnegie Institution of Washington, USA. Gas1-/- mice were 
generated and maintained in a 129sv/C57BL6 mixed background and genotyped as previously 
described [27]. Boc-/- mice were generated and maintained in a CD1/129sv mixed background and 
genotyped as previously described [46]. Gas1+/- mice were crossed with Boc+/- mice, to generate 
Gas1-/-; Boc-/-  compound mutants in a mixed background (129sv/C57BL/6/CD1). Timed-matings 
were set up such that noon of the day on which vaginal plugs were detected was considered as 
embryonic day (E) 0.5. 
 
Histological analysis 
For histological analysis, embryos were fixed in 4% paraformaldehyde (PFA) at 4˚C, dehydrated 
through a graded ethanol series, embedded in paraffin wax, sectioned at 7 mm and stained with 
haematoxylin and eosin (H&E). 
 
In Situ hybridization  
Radioactive section in situ hybridization was carried out as previously described [74]. Dark-field 
images of sections were photographed using a Zeiss Axioscop microscope and montages 
constructed using Adobe Photoshop CS. 
 
Cell packing and proliferation index per unit area assays 
A CPI was generated by dividing the total number of cells by the area of the region of interest. 
Assays for cell proliferation were carried out using a Zymed Bromodeoxyuridine (BrdU) Labeling 
and Detection Kit (Invitrogen), according to the manufacturer instructions. Mouse embryos were 
labeled with BrdU via intra-peritoneal injection into pregnant females (5 mg/100 g body weight) 2 
hours prior to sacrifice. Slides were photographed using a Zeiss Axioscop microscope (Germany).  
The imaging software package FIJI [66] was used to count BrdU-positive and total cells. 
Cells were counted in the mesenchyme of the anterior, medial and posterior palate. The lateral 
extent of the palate shelf was determined by drawing a perpendicular line from the ‘‘hinge’’ region 
to the opposite palatal surface [75]. Morphological segmentation of cells was performed using 
manual thresholding, followed by watersheding, to improve segmentation of closely neighboring 
cells [76]. Segmentation was performed twice, once for total and once for BrdU-positive cells. The 
palatal shelf area was measured by selecting the region of interest with the polygon selection tool. A 
proliferation index was first generated by dividing the number of positive cells by the total number 
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of cells. The proliferation index per unit area (PIPUA) was generated by dividing the proliferation 
index by the region of interest. Due to the small numeric scale of the data and to make it more 
easily presentable, CPI was multiplied by 10-3 and PIPUA was multiplied by 10-9. The graph 
illustrating the PIPUA is in a logarithmic scale to facilitate visualization of the data. 
 
Apoptosis 
Immunohistochemical detection of apoptotic cell death was carried out on histological sections 
using Terminal deoxynucleotidyl transferase-mediated deoxyUridine triPhosphate Nick End 
Labeling (TUNEL). TUNEL was carried out using an APOPTag® Plus Fluorescein In Situ 
Apoptosis Detection Kit (Chemicon International) according to the manufacturer’s instructions. 
Slides were photographed using a Zeiss Axioscop microscope (Germany). 
 
Statistical analysis 
The assumption of normality for each variable was checked with with the Shapiro-Wilk test [77]. 
The assumption of homoscedascity was carried out with an information matrix test, according to 
Cameron and Trivedi [78]. As both the CPI and the PIPUA were not normally distributed (p<0.001 
from the Shapiro-Wilk test for both), the median and interquartile range (IQR) are reported as 
descriptive statistics. The Kruskal-Wallis test was used to test for differences in CPI and PIPUA 
among the four groups. Differences among the four groups were identified by calculating 
coefficients and the corresponding 95% confidence intervals (95% CI) through generalized linear 
regression models, only if the null hypothesis was rejected with the Kruskal-Wallis test, so as to 
reduce the risk of increased Type II error. According to inspection of the histograms and to model 
fit, a Poisson distribution was adopted for the models with calculation of robust standard errors to 
control for mild violation of underlying assumptions [79]. As post hoc pairwise comparisons among 
groups were performed only in case of a statistically significant Kruskal-Wallis test and these were 
of explorative nature, no P-value correction was applied. All statistical analyses were conducted 
with a 2-sided α of 5% in Stata version 12 (StataCorp LP, College Station, TX) with the macros 
swilk, kwallis, and glm. 
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Figure Legends 
 
Figure 1- Palatogenesis in the mouse 
Representative histological frontal sections from the middle region of the developing palate at each 
indicated stage. (A) The secondary palate arises as paired outgrowths. (B) The PS initially grow 
vertically flanking the developing tongue. (C) The PS reorient to the horizontal position above the 
dorsum of the tongue in a process known as palatal shelf elevation. The fusion of palatal shelves 
involves the formation of a MES. (D) Subsequent disintegration of the MES allows mesenchymal 
confluence. Mc, Meckel's cartilage; mes, medial epithelium seam; mtb, molar tooth bud; ps, palatal 
shelf; t, tongue. Scale bar in D = 200 m for A-D. 
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Figure 2 - Normal expression of Shh, Ptch1, Gas1 and Boc during palate development  
Radioactive in situ hybridization showing frontal sections of medial developing palate at pre (E12.5 
A, D, G, J and E13.5 B, E, H, K) and post palatal shelf elevation (E14.5 C, F, I, and E15.5 L) and 
normal mRNA expression of Shh (A-C), Ptch1 (D-F), Gas1 (G-I) and Boc (J-L). Mc, Meckel's 
cartilage; mee, medial edge epithelium; mes, medial epithelium seam; nc, nasal cavity; nce, nasal 
cavity epithelium; oe, oral epithelium; ps, palatal shelf; rg, rugae; t, tongue. Scale bar in L = 200 
m for A-L. 
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Figure 3 - Histological phenotype of Gas1+/-; Boc+/-, Gas1-/-, Boc+/-, Boc-/- and Gas1-/-; Boc-/- 
palate 
Frontal sections of H&E stained E14.5 embryos through the anterior, medial and posterior palate. 
Gas1+/-; Boc+/- (A-C), Gas1-/-;Boc+/- (D-F), Boc-/- (G-I) and Gas1-/-; Boc-/- (J-L). The midline 
clefting within the posterior third of the tongue in the Gas1-/-; Boc-/- embryo is highlighted by the 
green arrowhead in L. Abnormal positioning of the vno is highlighted by the red arrowhead in K. 
The black asterisks (J-L) indicate the CP associated with a failure of palatal shelf elevation 
observed in Gas1-/-; Boc-/- mice. Mc, Meckel's cartilage; mes, medial epithelium seam; mtb, molar 
tooth bud; nc, nasal cavity; ns, nasal septum; ps, palatal shelf; t, tongue; vno, vomeronasal organ. 
Scale bar in L = 200 m for A-L 
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Figure 4 - Expression of Ptch1, Gli1 and Shh during palate development at E12.5 in Gas1; Boc 
compound mutants 
Radioactive in situ hybridization showing frontal sections of the medial developing palate at stage 
E12.5 of Gas1+/-; Boc+/- (A, D and G), Gas1-/-;Boc+/- (B, E and H) and Gas1-/-; Boc-/- (C, F and I) 
mice. Ptch1 (A-C), Gli1 (D-F) and Shh (G-I). III vt, third ventricle; ps, palatal shelf; t, tongue. Scale 
bar in I = 200 m for A-I. 
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Figure 5 - BrdU labeling and image analysis methodology 
(A) BrdU labeling. A perpendicular line from the palatal shelf ''hinge'' to the opposite palatal 
surface delimitates the analysed area. (B) The epithelium is deleted. (C) The region of interest is 
delimitated, and subsequently measured. (D) Thresholding for the total cells within the region of 
interest; the watershed plugin is applied for segmentation and the total cell counting is obtained. (E) 
Thresholding for the BrdU positive cells within the region of interest; the watershed plugin is 
applied for segmentation and the positive cell counting is obtained. Scale bar in A = 200 m for 
(A). Scale bar in E = 200 m for (B-E). 
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Figure 6 - Cell packing and proliferation in the developing palate of Gas1+/-; Boc+/-, Gas1-/-, 
Boc+/-, Boc-/- and Gas1-/-; Boc-/- mice at E14.5 
(A) Histogram for the CPI values indicates that the data is not normally distributed. (B) CPI box 
plots for the genotypes analysed. (C) Histogram for the PIPUA values indicates that the data is not 
normally distributed. (D) PIPUA box plots for the genotypes analysed. CPI, cell packing index; 
PIPUA, proliferation index per unit area. 
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Figure 7 - Cell survival in the developing palate of Gas1+/-; Boc+/-, Gas1-/-; Boc+/-, Boc-/- and Gas1-/-; Boc-/- mice at E14.5 
Frontal sections through the anterior, medial and posterior regions of the developing palate. Gas1+/-; Boc+/- (A-C, A'-C'), Gas1-/-;Boc+/- (D-F, D'-F'), 
Boc-/- (G-I, G'-I') and Gas1-/-; Boc-/- (J-L, J'-L'). 4′, 6-diamidino-2-phenylindole (DAPI) staining (A-L) to visualize cell nuclei and tissue architecture. 
Merged images (A'-L') used to distinguish between TUNEL-positive cells (green fluorescence) and background staining (orange). Red arrowheads in 
(J'-L') highlight the TUNEL-positive cells. Scale bar in L = 200 m for (A-L). mes, medial epithelial seam. Scale bar in L' = 100 m for (A'-L'). 
  
30 
 
Tables 
 
Table 1 - CPI descriptive analysis  
 
 
 
 
 
 
 
N, number of PS; IQR, interquartile range. 
 
Table 2 - CPI Poisson regression analysis 
GLM Poisson regression Pairwise comparisons (p values) 
Genotypes Coef 95% CI P value  Genotypes Boc-/- Gas1+/-; Boc+/- Gas1-/-; Boc+/- Gas1-/-; Boc-/- 
Boc-/- -0.21 -0.41,-0.03 0.025  Boc-/- _ _ _ _ 
Gas1+/-; Boc+/- Baseline _ _  Gas1+/-; Boc+/- 0.025 _ _ _ 
Gas1-/-; Boc+/- 0.61 0.45,0.77 <0.001  Gas1-/-; Boc+/- <0.001 <0.001 _ _ 
Gas1-/-; Boc-/- 0.05 -0.16,0.26 0.636  Gas1-/-; Boc-/- 0.040 0.636 <0.001 _ 
Coef, Poisson regression coefficients for the model; CI, confidence interval; GLM, generalized linear models. 
  
Genotypes N Median Q1-Q3 IQR Range 
Boc-/- 55 2.12 1.86-2.73 0.87 1.38-4.29 
Gas1+/-; Boc+/- 127 2.47 2.15-2.87 0.72 1.55-3.81 
Gas1-/-; Boc+/- 44 3.16 2.92-3.39 0.47 1.47-4.44 
Gas1-/-; Boc-/- 65 2.47 2.24-2.73 0.49 1.72-8.11 
Overall 291 2.51 2.15-2.96 0.81 1.38-8.11 
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Table 3 - PIPUA descriptive analysis 
 
 
 
 
 
 
 
N, number of PS; IQR, interquartile range. 
 
Table 4 - PIPUA Poisson regression analysis 
GLM Poisson regression Pairwise comparisons (p values) 
Genotypes Coef 95% CI P value  Genotypes Boc-/- Gas1+/-; Boc+/- Gas1-/-; Boc+/- Gas1-/-; Boc-/- 
Boc-/- 2612.54 2084.14,3140.95 <0.001  Boc-/- _ _ _ _ 
Gas1+/-; Boc+/- Baseline _ _  Gas1+/-; Boc+/- <0.001 _ _ _ 
Gas1-/-; Boc+/- 3.48 2.40,3.83 <0.001  Gas1-/-; Boc+/- <0.001 <0.001 _ _ 
Gas1-/-; Boc-/- 2.38 0.92,3.83 0.001  Gas1-/-; Boc-/- <0.001 0.001 0.228 _ 
Coef, Poisson regression coefficients for the model; CI, confidence interval; GLM, generalized linear models. 
 
Genotypes N Median Q1-Q3 IQR Range 
Boc-/- 55 2175.3 1170.19-3184.81 2014.62 585.13-10055.89 
Gas1+/-; Boc+/- 127 2.51 2.09-3.24 1.15 1.23-8.17 
Gas1-/-; Boc+/- 44 4.90 3.63-8.15 4.52 2.45-21.18 
Gas1-/-; Boc-/- 65 3.63 2.30-5.38 3.09 0.96-40.18 
Overall 291 3.52 2.39-8.17 5.78 0.96-10055.99 
 
